• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在保乳治疗中,美容效果和生活质量紧密相连。

Cosmetic outcome and quality of life are inextricably linked in breast-conserving therapy.

作者信息

Volders José H, Negenborn Vera L, Haloua Max H, Krekel Nicole M A, Jóźwiak Katarzyna, Meijer Sybren, M van den Tol Petrousjka

机构信息

Department of Surgical Oncology, VU University Medical Center, Amsterdam, The Netherlands.

Department of Plastic Surgery, VU University Medical Center, Amsterdam, The Netherlands.

出版信息

J Surg Oncol. 2017 Jun;115(8):941-948. doi: 10.1002/jso.24615. Epub 2017 Mar 23.

DOI:10.1002/jso.24615
PMID:28334419
Abstract

INTRODUCTION

Cosmetic results and quality of life (QoL) are increasingly important in the treatment of breast cancer. This study was designed to determine the relationship between QoL and both subjectively and objectively measured cosmetic outcomes of breast-conserving therapy (BCT), and its course over time.

METHODS

A total of 128 breast cancer patients who underwent BCT as part of a prospective randomized controlled trial were included. QoL was measured using the EORTC QLQ-C30 and QLQ-BR23 at baseline, 3, 6, 12, and 36 months. Cosmetic outcome was determined by patient self-evaluation, panel evaluation, and BCCT.core software.

RESULTS

By 36 months, all QoL factors except arm symptoms had returned to baseline or improved. After adjustment for patient and tumor characteristics, a significantly better QoL in terms of body image, pain, and arm and breast symptoms was found for good/excellent cosmetic outcomes compared to fair/poor outcomes, as measured by both patient self-evaluation and panel evaluation. The BCCT.core showed no correlation with any QoL factors.

CONCLUSION

There is a high correlation between poor cosmetic outcome and low scores on quality of life indicators, underlining the importance of achieving a good cosmetic outcome after BCT.

摘要

引言

在乳腺癌治疗中,美容效果和生活质量(QoL)愈发重要。本研究旨在确定生活质量与保乳治疗(BCT)主观及客观测量的美容效果之间的关系,以及其随时间的变化过程。

方法

纳入128例作为前瞻性随机对照试验一部分接受保乳治疗的乳腺癌患者。在基线、3个月、6个月、12个月和36个月时,使用欧洲癌症研究与治疗组织生活质量核心问卷(EORTC QLQ-C30)和乳腺癌特异性问卷(QLQ-BR23)测量生活质量。美容效果由患者自我评估、专家小组评估和BCCT.core软件确定。

结果

到36个月时,除手臂症状外,所有生活质量因素均恢复至基线水平或有所改善。在调整患者和肿瘤特征后,与一般/差的美容效果相比,通过患者自我评估和专家小组评估发现,在身体形象、疼痛以及手臂和乳房症状方面,良好/优秀的美容效果具有显著更好的生活质量。BCCT.core与任何生活质量因素均无相关性。

结论

美容效果差与生活质量指标得分低之间存在高度相关性,强调了保乳治疗后获得良好美容效果的重要性。

相似文献

1
Cosmetic outcome and quality of life are inextricably linked in breast-conserving therapy.在保乳治疗中,美容效果和生活质量紧密相连。
J Surg Oncol. 2017 Jun;115(8):941-948. doi: 10.1002/jso.24615. Epub 2017 Mar 23.
2
Effect of cosmetic outcome on quality of life after breast cancer surgery.乳腺癌手术后美容效果对生活质量的影响。
Eur J Surg Oncol. 2015 Mar;41(3):426-32. doi: 10.1016/j.ejso.2014.12.002. Epub 2014 Dec 19.
3
Intraoperative ultrasound guidance in breast-conserving surgery shows superiority in oncological outcome, long-term cosmetic and patient-reported outcomes: Final outcomes of a randomized controlled trial (COBALT).保乳手术中术中超声引导在肿瘤学结局、长期美容效果及患者报告结局方面显示出优越性:一项随机对照试验(COBALT)的最终结果
Eur J Surg Oncol. 2017 Apr;43(4):649-657. doi: 10.1016/j.ejso.2016.11.004. Epub 2016 Nov 23.
4
Evaluation of cosmetic outcome following breast-conserving therapy in trials: panel versus digitalized analysis and the role of PROMs.试验中保乳治疗后美容效果的评估:专家小组评估与数字化分析及患者报告结局量表的作用
Breast J. 2018 Jul;24(4):519-525. doi: 10.1111/tbj.12980. Epub 2018 Jan 8.
5
Quality of life and satisfaction after breast cancer operation.乳腺癌手术后的生活质量和满意度。
Arch Gynecol Obstet. 2010 Jul;282(1):75-82. doi: 10.1007/s00404-009-1302-y. Epub 2009 Dec 4.
6
Proposal for a gold standard for cosmetic evaluation after breast conserving therapy: Results from the St George and Wollongong Breast Boost trial.保乳治疗后美容效果评估金标准的提议:圣乔治和卧龙岗乳房强化试验的结果
J Med Imaging Radiat Oncol. 2017 Dec;61(6):819-825. doi: 10.1111/1754-9485.12645. Epub 2017 Aug 18.
7
The influence of simultaneous integrated boost, hypofractionation and oncoplastic surgery on cosmetic outcome and PROMs after breast conserving therapy.保乳治疗后同步整合加量、大分割放疗和肿瘤整形手术对美容效果和患者报告结局量表的影响。
Eur J Surg Oncol. 2015 Oct;41(10):1411-6. doi: 10.1016/j.ejso.2015.07.011. Epub 2015 Jul 31.
8
The COSMAM TRIAL a prospective cohort study of quality of life and cosmetic outcome in patients undergoing breast conserving surgery.COSMAM 试验:保乳手术患者生活质量和美容结局的前瞻性队列研究。
BMC Cancer. 2018 Apr 23;18(1):456. doi: 10.1186/s12885-018-4368-8.
9
Aesthetic result after breast-conserving therapy is associated with quality of life several years after treatment. Swedish women evaluated with BCCT.core and BREAST-Q™.保乳治疗后的美学效果与治疗后数年的生活质量相关。瑞典女性采用BCCT.core和BREAST-Q™进行评估。
Breast Cancer Res Treat. 2017 Aug;164(3):679-687. doi: 10.1007/s10549-017-4306-5. Epub 2017 May 23.
10
Assessment of cosmesis and quality of life and their correlation using novel, validated methods in breast cancer patients who had undergone breast conservation therapy.评估采用新型经过验证的方法在接受保乳治疗的乳腺癌患者中的美容效果和生活质量及其相关性。
Gulf J Oncolog. 2021 May;1(36):21-29.

引用本文的文献

1
The association between breast fibrosis, cosmetic outcomes, and long-term health-related quality of life after breast-conserving therapy: a multicenter cross-sectional observational cohort study.保乳治疗后乳腺纤维化、美容效果及长期健康相关生活质量之间的关联:一项多中心横断面观察性队列研究。
Breast. 2025 Jul 14;83:104541. doi: 10.1016/j.breast.2025.104541.
2
Resection Ratios and Tumor Eccentricity in Breast-Conserving Surgery Specimens for Surgical Accuracy Assessment.保乳手术标本中的切除率和肿瘤偏心度用于手术准确性评估
Cancers (Basel). 2024 May 9;16(10):1813. doi: 10.3390/cancers16101813.
3
Diffuse reflectance spectroscopy for accurate margin assessment in breast-conserving surgeries: importance of an optimal number of fibers.
用于保乳手术中准确切缘评估的漫反射光谱法:最佳光纤数量的重要性。
Biomed Opt Express. 2023 Jul 10;14(8):4017-4036. doi: 10.1364/BOE.493179. eCollection 2023 Aug 1.
4
Longitudinal cosmetic outcome after planned IORT boost with low kV X-rays-monocentric results from the TARGIT BQR registry.使用低千伏X射线进行计划性术中放疗加量后的纵向美容效果——来自TARGIT BQR注册研究的单中心结果
Transl Cancer Res. 2023 Jul 31;12(7):1715-1726. doi: 10.21037/tcr-23-88. Epub 2023 Jun 27.
5
How breast cancer therapies impact body image - real-world data from a prospective cohort study collecting patient-reported outcomes.乳腺癌治疗如何影响身体形象 - 一项前瞻性队列研究收集患者报告结果的真实世界数据。
BMC Cancer. 2023 Jul 28;23(1):705. doi: 10.1186/s12885-023-11172-y.
6
Toward Intraoperative Margin Assessment Using a Deep Learning-Based Approach for Automatic Tumor Segmentation in Breast Lumpectomy Ultrasound Images.迈向使用基于深度学习的方法进行术中切缘评估,以实现乳腺肿块切除术超声图像中的肿瘤自动分割。
Cancers (Basel). 2023 Mar 8;15(6):1652. doi: 10.3390/cancers15061652.
7
A fully automatic framework for evaluating cosmetic results of breast conserving therapy.一种用于评估保乳治疗美容效果的全自动框架。
Mach Learn Appl. 2022 Dec 15;10. doi: 10.1016/j.mlwa.2022.100430. Epub 2022 Nov 2.
8
Evaluation of breast cosmetic changes with a computer-software; the breast cancer conservative treatment cosmetic results (BCCT. core) in hypofractionated whole breast irradiation after breast-conserving surgery-supplementary analysis of multicenter single-arm confirmatory trial: JCOG0906.计算机软件评估乳房美容变化;保乳手术后短程分割全乳房照射的乳腺癌保乳治疗美容结果(BCCT.core):多中心单臂确证性试验的补充分析:JCOG0906。
Breast Cancer. 2022 Nov;29(6):1042-1049. doi: 10.1007/s12282-022-01384-8. Epub 2022 Jul 21.
9
Optical tissue measurements of invasive carcinoma and ductal carcinoma in situ for surgical guidance.光学组织测量浸润性癌和导管原位癌以指导手术。
Breast Cancer Res. 2021 May 22;23(1):59. doi: 10.1186/s13058-021-01436-5.
10
Margin Assessment and Re-excision Rates for Patients Who Have Neoadjuvant Chemotherapy and Breast-Conserving Surgery.新辅助化疗和保乳手术后患者的切缘评估和再次切除率。
Ann Surg Oncol. 2021 Sep;28(9):5142-5148. doi: 10.1245/s10434-020-09524-0. Epub 2021 Feb 26.